Lifevantage Corporation Common Stock (Delaware) (LFVN) Stock Price

LFVNStock

$6.84−47.71%52W

Market Cap$86.29M

P/E8.35x

PEG Ratio0.36

Div yield2.41%

Beta0.76

LFVN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)27.50%

Price vs S&P 500 (4W)3.32%

PEG Ratio0.36

VGM Score54.30

P/E Ratio (Annual)8.35x

Indicated Dividend Yield (Annual)2.41%

P/CF (Annual)6.89x

Book Value / Share (Quarterly)$2.64

P/TBV (Annual)4.73x

Indicated Dividend (Annual)$0.20

Revenue Growth (3Y)3.45%

Cash Flow / Share (Quarterly)$0.30

Payout Ratio (TTM)39.66%

Price vs S&P 500 (YTD)-0.92%

Gross Margin (TTM)78.14%

Net Profit Margin (TTM)2.94%

EPS (TTM)$0.45

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$0.45

Revenue Growth (5Y)-0.38%

EPS (Annual)$0.76

Dividend / Share (Annual)$0.17

ROI (Annual)28.30%

Gross Margin (Annual)80.37%

Net Profit Margin (5Y Avg)2.86%

Cash / Share (Quarterly)$0.99

P/E Basic Excl Extra (TTM)14.23x

Revenue Growth QoQ (YoY)-25.20%

EPS Growth (5Y)-0.84%

P/E Normalized (Annual)8.35x

ROA (Last FY)13.63%

Revenue Growth TTM (YoY)-12.15%

EBITD / Share (TTM)$0.73

ROE (5Y Avg)18.34%

Operating Margin (TTM)3.37%

Cash Flow / Share (Annual)$0.85

P/B Ratio2.46x

P/B Ratio (Quarterly)1.66x

Net Income / Employee (Annual)$42,300

EV / Revenue (TTM)0.36x

Net Interest Coverage (TTM)21.00x

ROA (TTM)8.96%

EPS Growth QoQ (YoY)-58.76%

EV / EBITDA (TTM)7.38x

EPS Incl Extra (Annual)$0.76

Current Ratio (Annual)1.87x

Quick Ratio (Quarterly)0.85x

3-Month Avg Trading Volume0.35M

52-Week Price Return-47.71%

EV / Free Cash Flow (Annual)6.60x

P/E Incl Extra (TTM)14.23x

Revenue / Employee (TTM)$841,900

Tangible BV / Share (Quarterly)$2.39

P/S Ratio (Annual)0.36x

Asset Turnover (Annual)3.18x

52-Week High$14.28

Operating Margin (5Y Avg)4.02%

EPS Excl Extra (Annual)$0.76

CapEx CAGR (5Y)-12.55%

Tangible BV CAGR (5Y)1.20%

26-Week Price Return38.74%

Quick Ratio (Annual)0.89x

13-Week Price Return27.37%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.96x

Enterprise Value$69.39M

Revenue / Share Growth (5Y)1.98%

Asset Turnover (TTM)3.04x

Book Value / Share Growth (5Y)3.70%

Revenue / Employee (Annual)$985,000

Inventory Turnover (Annual)2.51x

Pretax Margin (Annual)5.36%

Cash / Share (Annual)$1.63

3-Month Return Std Dev104.48%

Gross Margin (5Y Avg)80.70%

Net Income / Employee (TTM)$24,800

EBITDA CAGR (5Y)-3.43%

EBITDA Interim CAGR (5Y)-4.11%

ROE (Last FY)28.30%

Net Interest Coverage (Annual)115.62x

EPS Basic Excl Extra (Annual)$0.76

P/FCF (TTM)12.56x

Receivables Turnover (TTM)69.02x

EV / Free Cash Flow (TTM)18.38x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.45

Receivables Turnover (Annual)73.21x

ROI (TTM)17.15%

P/S Ratio (TTM)0.42x

Pretax Margin (5Y Avg)3.90%

Revenue / Share (Annual)$17.60

Tangible BV / Share (Annual)$2.77

Forward P/E13.77x

Free OCF CAGR (5Y)-7.66%

Price vs S&P 500 (52W)-66.02%

P/E Ratio (TTM)14.23x

EPS Growth TTM (YoY)-36.01%

Year-to-Date Return11.04%

5-Day Price Return7.38%

EPS Normalized (Annual)$0.76

ROA (5Y Avg)8.61%

Net Profit Margin (Annual)4.29%

Month-to-Date Return6.38%

Cash Flow / Share (TTM)$0.49

EBITD / Share (Annual)$1.18

EPS Growth (3Y)47.22%

Operating Margin (Annual)5.34%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)12.58x

ROI (5Y Avg)18.34%

P/E Excl Extra (TTM)14.23x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.45

P/TBV (Quarterly)1.83x

Payout Ratio (Annual)21.08%

P/B Ratio (Annual)4.69x

Dividend / Share (TTM)$0.18

Inventory Turnover (TTM)2.10x

Pretax Margin (TTM)3.46%

Book Value / Share (Annual)$2.79

Price vs S&P 500 (13W)24.58%

Net Margin Growth (5Y)-2.78%

Dividend Yield (TTM)2.79%

Beta0.76x

P/FCF (Annual)7.79x

Revenue / Share (TTM)$15.43

ROE (TTM)17.15%

52-Week Low$3.90

vGradeB

gGradeD

mGradeB

vgmGradeC

LFVN Earnings Surprise History

Q2 250.17est. 0.20

Q3 250.18est. 0.19

Q4 250.15est. 0.15

Q1 260.12est. 0.16

LFVN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
LFVNLifevantage Corporation Common Stock (Delaware)	B	D	B	$6.84
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Lifevantage Corporation Common Stock (Delaware)

LifeVantage develops and distributes nutraceutical supplements and skincare products, including Protandim, LifeVantage TrueScience, Axio energy drinks, and PhysIQ. The company operates in ten countries across North America, Asia-Pacific, and Europe. Its products are positioned as scientifically-validated wellness solutions for health-conscious consumers.